Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit

British Journal of Anaesthesia

Volumn 108, Issue 4, 2012, Pages 586-593

  Le Sache F ^a,b   Le Bonniec, B ^a,b   Gaussem, P ^a,b,c   Dizier, B ^a,b   Tagzirt, M ^a,b   Godier, A ^a,b,d   Emmerich, J ^a,b   Samama, C M ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d HÔTEL DIEU   (France)

Author keywords

arterial thrombosis; bleeding; haemodilution; prothrombin complex concentrates; recombinant activated factor VII

Indexed keywords

HETASTARCH; PLACEBO; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BLEEDING TIME; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; DRUG SAFETY; HEMODILUTION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL;

EID: 84858418494     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer450     Document Type: Article

References (35)

1. Hardy J-F, de Moerloose P, Samama CM, Groupe d'intérêt en Hémostase Périopé ratoire. Massive transfusion and coagulopathy: Pathophysiology and implications for clinical management. Can J Anaesth 2006; 53(6 Suppl.): S40-58
2. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: An updated European guideline. Crit Care 2010; 14: R52
3. Diprose P, Herbertson MJ, O'Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: Randomized double-blind placebo-controlled pilot study. Br J Anaesth 2005; 95: 596-602
4. Schöchl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEMw)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55
5. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth 2005; 94: 592-5
6. Butwick AJ, Riley ET, Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth 2005; 95: 558 (author reply)
7. Spahn DR, Tucci MA, Makris M. Is recombinant FVIIa the magic bullet in the treatment of major bleedinǧBr J Anaesth 2005; 94: 553-5
8. Cameron P, Phillips L, Balogh Z, et al. The use of recombinant activated factor VII in trauma patients: Experience fromthe Australian and New Zealand haemostasis registry. Injury 2007; 38: 1030-8
9. Kluger Y, Riou B, Rossaint R, et al. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: Post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial. Crit Care 2007; 11: R85
10. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. J Am Med Assoc 2006; 295: 293-8
11. Khan ZH, Soltani AE, Rahmani P. Postoperative pulmonary thromboembolism possibly associated with recombinant activated factor VII infusion for the treatment of uncontrolled hemorrhage during vertebral instrumentation. J Anesth 2007; 21: 258-60
12. Samama CM. Prothrombin complex concentrates: A brief review. Eur J Anaesthesiol 2008; 25: 784-9
13. Lankiewicz MW, Hays J, Friedman KD, Tinkoff G, Blatt PM. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 2006; 4: 967-70
14. Leissinger CA, Blatt PM, Hoots WK, Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature. Am J Hematol 2008; 83: 137-43
15. Schick KS, Fertmann JM, Jauch K-W, Hoffmann JN. Prothrombin complex concentrate in surgical patients: Retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009; 13: R191
16. Kohler M. Thrombogenicity of prothrombin complex concentrates. Thromb Res 1999; 95(4 Suppl. 1): S13-7
17. Bagot CN, Cregg R, Patel RK, Shariff A, Arya R. Perioperative myocardial infarction in a patient receiving low-dose prothrombin complex concentrates. Thromb Haemost 2007; 98: 1141-2
18. Folts J, Rowe G. Cyclical reductions in coronary blood flow in coronary arteries with fixed partial obstruction and their inhibition with aspirin. Fed Proc 1974; 33: 413
19. Sturgeon SA, Jones C, Angus JA, Wright CE. Adaptation of the Folts and electrolytic methods of arterial thrombosis for the study of anti-thrombotic molecules in small animals. J Pharmacol Toxicol Methods 2006; 53: 20-9
20. Fattorutto M, Tourreau-Pham S, Mazoyer E, et al. Recombinant activated factor VII decreases bleeding without increasing arterial thrombosis in rabbits. Can J Anaesth 2004; 51: 672-9
21. Delaporte-Cerceau S, Samama CM, Riou B, Bonnin P, Guillosson JJ, Coriat P. Ketorolac and enoxaparin affect arterial thrombosis and bleeding in the rabbit. Anesthesiology 1998; 88: 1310-7
22. Godier A, Mazoyer E, Cymbalista F, Cupa M, Samama CM. Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: A blind study. J Thromb Haemost 2007; 5: 244-9
23. Louvain-Quintard VB, Bianchini EP, Calmel-Tareau C, Tagzirt M, Le Bonniec BF. Thrombin-activable factor X re-establishes an intrinsic amplification in tenase-deficient plasmas. J Biol Chem 2005; 280: 41352-9
24. Siller-Matula JM, Plasenzotti R, Spiel A, Quehenberger P, Jilma B. Interspecies differences in coagulation profile. Thromb Haemost 2008; 100: 397-404
25. Hindy-François C, Bachelot-Loza C, Le Bonniec B, et al. Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrel. Thromb Haemost 2010; 104: 823-30
26. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009; 22: 267-74
27. Dickneite G, Pragst I. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth 2009; 102: 345-54
28. Dickneite G, Dörr B, Kaspereit F, Tanaka KA. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma 2010; 68: 1151-7
29. Pragst I, Kaspereit F, Dörr B, Dickneite G. Prothrombin complex concentrate (Beriplex P/N) for control of bleeding after kidney trauma in a rabbit dilutional coagulopathy model. Thromb Res 2010; 125: 272-7
30. Bruce D, Nokes TJ. Prothrombin complex concentrate (Beriplex P/ N) in severe bleeding: Experience in a large tertiary hospital. Crit Care 2008; 12: R105
31. Viuff D, Lauritzen B, Pusateri AE, Andersen S, Rojkjaer R, Johansson PI. Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven). Br J Anaesth 2008; 101: 324-31
32. Gabriel DA, Li X, Monroe DM III, Roberts HR. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets. J Thromb Haemost 2004; 2: 1816-22
33. Butenas S, Brummel KE, Bouchard BA, Mann KG. How factor VIIa works in hemophilia. J Thromb Haemost 2003; 1: 1158-60
34. Ouaknine-Orlando B, Samama CM, Riou B, et al. Role of the hematocrit in a rabbit model of arterial thrombosis and bleeding. Anesthesiology 1999; 90: 1454-61
35. Charbonneau S, Girard F, Boudreault D, Ruel M, Hardy JF. Anesthetic technique does not affect the performance of a rabbit model of arterial cyclic flow reductions: A pilot study. Can J Anaesth 2007; 54: 269-75